P3.16-41 Postoperative Pembrolizumab for the Patients With Pathologic Stage I Adenocarcinoma With Solid or Micropapillary Pattern

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1948
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.16-43 Is Sublobar Resection for Stage I Invasive Adenocarcinoma (≤2-Cm) Feasible?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Risk Factors of Postoperative Recurrences in Patients With Clinical Stage I NSCLC

World Journal of Surgical Oncology
SurgeryOncology
2014English

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

JAMA Oncology
Cancer ResearchOncology
2019English

Histopathological Features and Prognostic Significance of the Micropapillary Pattern in Lung Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2008English

MA01.02 Histologic Subtyping in Pathologic Stage I Lung Adenocarcinoma Provides Risk-Based Stratification for Surveillance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Genetic Alterations in Lung Adenocarcinoma With a Micropapillary Component

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

P3.16-28 Surgery of Stage I Non-Small Cell Lung Cancer in Patients Aged 70 Years or Older

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.16-63 the Value of Adjuvant Chemotherapy in Patients With Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.09-20 Minor Components of Solid Pattern Is a Significant Poor Prognostic Factor in Pathological Stage I Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy